Brain Health title image

Brain Health

Mental & Cognitive Health

Brain health connects the thinking skills you use today with the ability to remain capable and engaged over time. Memory, learning, attention, and mental flexibility each contribute to familiar activities, from following a conversation to taking on a new skill. Supporting those abilities is part of maintaining independence and quality of life. The brain depends on a continuous supply of energy and a range of nutrients involved in cell membranes, nerve signaling, and normal maintenance. Different ingredients focus on particular aspects of this foundation or on specific cognitive priorities. Understanding their role helps keep a brain-health routine purposeful and relevant to your circumstances. The most useful priorities come from everyday life. You may want to retain new information more comfortably, stay mentally engaged, or support long-term cognitive wellbeing. A clear focus makes it easier to choose appropriate support and recognize meaningful changes in the activities that matter to you.

Warnings

  • Check medicine interactions: Ask a pharmacist or clinician to review your exact products alongside your medicines. The ingredient, amount, and treatment determine which combinations are suitable.
  • Review potent cognitive ingredients: Review compounds such as huperzine and vinpocetine individually for suitability and interactions. Agree any ongoing use with an appropriately qualified professional.
  • Assess new cognitive changes: New, progressive, or function-limiting changes in memory or thinking need assessment. Supplements should not delay a review of possible medical, sleep-related, or medicine-related causes.
  • Tell your surgical team: Share a complete supplement list before a procedure. The team can advise which products to stop and when; a single stopping interval is not appropriate for every supplement or procedure.
Ingredient overview

Goal guidance

Lifestyle changes

Stay physically active and make room for learning, social contact, and activities that hold your attention. Support regular sleep and keep hearing, vision, and routine health care up to date.

Diet changes

Include varied plants, whole grains, legumes, protein foods, and sources of unsaturated fat. Pay extra attention to nutritional intake when appetite is reduced or food choices are limited.

Who this is for

Adults interested in memory, learning, mental clarity, and maintaining everyday cognitive function over time.

Who should be careful

Review cognitive supplements carefully if you take several medicines, particularly products containing huperzine or vinpocetine. New or progressive changes in memory or everyday function need assessment.

Expected timeline

Look for meaningful changes in everyday activities rather than a single feeling of stimulation. Long-term brain support is an ongoing routine, while individual ingredients have their own patterns of use.

Common mistakes

Choosing too many brain supplements at once can make their effects difficult to separate. Start with a clear priority and keep sleep, movement, and learning part of the plan.

Ingredients

Folate Vitamins
Impact
Highest effect
Typical dose400–800 mcg / day
Folate (Vitamin B9) is a crucial cofactor in the production of key neurotransmitters like dopamine, serotonin, and norepinephrine. It is also vital for the methylation cycle, which helps keep homocysteine levels in check. Elevated homocysteine is a known risk factor for vascular damage in the brain and cognitive decline, making folate a foundational nutrient for long-term brain health.

Study evidence

90 studies

Folate is important for brain development, and low status is associated with poorer cognition. Supplementation may help selected people with low folate or cognitive impairment, but benefits are inconsistent and extra folate has not been shown to broadly protect already well-nourished adults from cognitive decline.

View ingredient ->
Magnesium Minerals
Impact
Highest effect
Typical dose200–400 mg / day
Magnesium is a critical cofactor in hundreds of enzymatic reactions in the brain. It regulates neurotransmitter release, gates the NMDA receptor involved in learning and memory, and helps calm the nervous system by balancing cortisol, thereby improving sleep quality which is vital for memory consolidation.

Study evidence

86 studies

Magnesium has benefits in specific neurological treatment settings, but these do not establish broad brain protection from an everyday supplement. The wider research is mixed, and prevention of cognitive decline or dementia through supplementation remains unproven.

View ingredient ->
Thiamin Vitamins
Impact
Highest effect
Typical dose1.2–100 mg / day
Thiamin (Vitamin B1) is a critical cofactor for enzymes involved in glucose metabolism, the brain's primary fuel source. It is also required for the synthesis of acetylcholine and GABA. Deficiency leads to severe neurological impairment, making adequate levels foundational for basic cognitive processing and neuronal health.

Study evidence

48 studies

Thiamin is essential for brain function, and deficiency can cause serious neurological injury. Replacing it is important in deficiency-related illness, but the supplied research does not establish that extra thiamin reliably improves cognition or prevents dementia in people with adequate status.

View ingredient ->
Vitamin B12 Vitamins
Impact
Highest effect
Typical dose500–2500 mcg / day
Vitamin B12 is essential for the health and integrity of the central nervous system. It plays a direct role in the synthesis of myelin, the fatty substance that insulates nerve fibers and ensures rapid communication between neurons. Deficiency, common in older adults and plant-based diets, can lead to irreversible neurological damage and severe cognitive impairment.

Study evidence

74 studies

Vitamin B12 is important for brain function, and treating clear deficiency can improve related neurological problems. However, supplementation has not consistently improved memory or thinking in people without overt deficiency, and it is not established as a way to prevent dementia.

View ingredient ->
Vitamin B6 Vitamins
Impact
Highest effect
Typical dose10–50 mg / day
Vitamin B6 is required for over 100 enzyme reactions in the body, including the critical final step in synthesizing important neurotransmitters such as serotonin, dopamine, and GABA. Adequate B6 levels are essential for maintaining proper neurological function, emotional balance, and cognitive processing.

Study evidence

29 studies

Vitamin B6 supports normal brain function, and low levels are associated with poorer cognition in some populations. However, the supplied evidence does not establish that B6 supplements alone improve memory or prevent dementia; favorable findings often concern vitamin combinations or changes in nutritional status.

View ingredient ->
Vitamin D Vitamins
Impact
Highest effect
Typical dose1000–4000 IU / day
Vitamin D receptors are widely distributed throughout the brain, where it helps regulate the synthesis of neurotransmitters and supports nerve growth. Correcting common deficiencies is linked to improved mood and cognitive performance, as well as reduced risk of age-related cognitive decline.

Study evidence

94 studies

Low Vitamin D levels are associated with poorer cognition and greater dementia risk, but supplementation has not reliably improved brain health. Some pooled analyses and trials report cognitive benefits, while substantial controlled research remains negative, including in adults with mild to moderate deficiency.

View ingredient ->

Studies

Explore published research for this goal.

Sources

Up to five highest-ranked published examples per ingredient. Study counts and charts include all published studies for the connection.

  1. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis.
    Wang Z; Zhu W; Xing Y; Jia J; Tang Y · Nutrition reviews · 2022
    Meta-analysis46,175 participants95 studies pooledFolate
  2. Folate and long-chain polyunsaturated fatty acid supplementation during pregnancy has long-term effects on the attention system of 8.5-y-old offspring: a randomized controlled trial.
    Catena A; Muñoz-Machicao JA; Torres-Espínola FJ; Martínez-Zaldívar C; Diaz-Piedra C; Gil A; Haile G; Györei E; Molloy AM; Decsi T; Koletzko B; Campoy C · The American journal of clinical nutrition · 2016
    Randomized trial136 participantsFolate
  3. Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial.
    Liu Y; Yu Z; Cai Z; Zhao L; Wang Y; Guo Y; Su X; Miao Y; Yi B; Wang Y; Zhang X · The journal of prevention of Alzheimer's disease · 2025
    Randomized trial220 participantsFolate
  4. Circulating folate concentrations and the risk of mild cognitive impairment: A prospective study on the older Chinese population without folic acid fortification.
    Fu J; Liu Q; Zhu Y; Sun C; Duan H; Huang L; Zhou D; Wang Z; Zhao J; Li Z; Ma F; Li W; Liu H; Zhang X; Chen Y; Wang G; Du Y; Huang G · European journal of neurology · 2022
    Cohort study3,974 participantsFolate
  5. Normal-But-Low Serum Folate Levels and the Risks for Cognitive Impairment.
    Jang S; Han JW; Shin J; Kim TH; Kwak KP; Kim K; Kim BJ; Kim SG; Kim JL; Kim TH; Moon SW; Park JY; Park JH; Byun S; Suh SW; Seo J; So Y; Ryu SH; Youn JC; Lee KH; Lee DY; Lee DW; Lee SB; Lee JJ; Lee JR; Jeong H; Jeong HG; Jhoo JH; Han K; Hong JW; Kim KW · Psychiatry investigation · 2020
    Cohort study3,910 participantsFolate
  6. Antenatal magnesium sulfate and neuroprotection.
    Doyle LW · Current opinion in pediatrics · 2012
    Meta-analysis6,145 participants5 studies pooledMagnesium
  7. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P · Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC · 2020
    Guideline / consensus4,446 participantsMagnesium
  8. Magnesium Sulfate Before Preterm Birth for Neuroprotection: An Updated Cochrane Systematic Review.
    Shepherd ES; Goldsmith S; Doyle LW; Middleton P; Marret S; Rouse DJ; Pryde P; Wolf HT; Crowther CA · Obstetrics and gynecology · 2024
    Systematic review5,917 participants6 studies pooledMagnesium
  9. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
    Wolf HT; Huusom LD; Henriksen TB; Hegaard HK; Brok J; Pinborg A · BJOG : an international journal of obstetrics and gynaecology · 2020
    Meta-analysis5,917 participants6 studies pooledMagnesium
  10. Magnesium sulfate and fetal neuroprotection: overview of clinical evidence.
    Chollat C; Marret S · Neural regeneration research · 2020
    Narrative reviewMagnesium
  11. Can thiamine substitution restore cognitive function in alcohol use disorder?
    Listabarth S; Vyssoki B; Marculescu R; Gleiss A; Groemer M; Trojer A; Harrer C; Weber S; König D · Alcohol and alcoholism (Oxford, Oxfordshire) · 2023
    Clinical trial50 participantsThiamin
  12. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy.
    Galvin R; Bråthen G; Ivashynka A; Hillbom M; Tanasescu R; Leone MA; EFNS · European journal of neurology · 2011
    Guideline / consensusThiamin
  13. Diagnosis and treatment of Wernicke's encephalopathy: A systematic literature review.
    Cantu-Weinstein A; Branning R; Alamir M; Weleff J; Do M; Nero N; Anand A · General hospital psychiatry · 2024
    Systematic review688 participants27 studies pooledThiamin
  14. Vitamin Supplementation and Dementia: A Systematic Review.
    Gil Martínez V; Avedillo Salas A; Santander Ballestín S · Nutrients · 2022
    Systematic reviewThiamin
  15. Association between dietary vitamin B1 intake and cognitive function among older adults: a cross-sectional study.
    Jia W; Wang H; Li C; Shi J; Yong F; Jia H · Journal of translational medicine · 2024
    Cross-sectional study2,422 participantsThiamin
  16. Relationship between vitamin B12 levels and motor development: A systematic review.
    Dos Santos MERA; da Silva KG; da Silva Souza AP; da Silva ABJ; da Silva RF; da Silva EHA; de Souza SL; Barros WMA · Clinical nutrition ESPEN · 2024
    Systematic review1,559 participants8 studies pooledVitamin B12
  17. Vitamin B12 supplementation improves cognitive function in middle aged and elderly patients with cognitive impairment.
    Zhou L; Bai X; Huang J; Tan Y; Yang Q · Nutricion hospitalaria · 2023
    Randomized trial115 participantsVitamin B12
  18. Structural and Functional Brain Changes Associated with Vitamin B12 Deficiency using Magnetic Resonance Imaging: A Systematic Review and Meta-analysis.
    Alghamdi A · Current medical imaging · 2023
    Meta-analysis12 studies pooledVitamin B12
  19. Maternal vitamin B12, vitamin D, and folic acid status during pregnancy and child neurodevelopment: a systematic review.
    Franco L; de Andrade CVF; Margini LV; Sousa N · Frontiers in neuroscience · 2026
    Systematic review22 studies pooledVitamin B12
  20. Higher vitamin B12 from mid- to late life is related to slower rates of cognitive decline.
    Marino FR; Rogers G; Miller JW; Selhub J; Mez J; Crane PK; Mukherjee S; Saykin AJ; Hohman TJ; Trittschuh EH; Au R; Jacques PF; Hwang PH · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Cohort study1,994 participantsVitamin B12
  21. Vitamin B12, B6, or Folate and Cognitive Function in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.
    Zhang C; Luo J; Yuan C; Ding D · Journal of Alzheimer's disease : JAD · 2021
    Meta-analysis21 studies pooledVitamin B6
  22. Relationship between serum pyridoxal 5'-phosphate concentration and cognitive function in older Japanese.
    Itoh K; Kuwabara A; Otsuka R; Sugimoto T; Sakurai T; Niida S; Ao M; Tanaka K; Takenaka S; Kanouchi H · Journal of clinical biochemistry and nutrition · 2025
    Cross-sectional study266 participantsVitamin B6
  23. A randomized, controlled trial to evaluate the efficacy of pyridoxine and ascorbic acid on cognitive function and quality of life in post-menopausal women.
    Dhivya K; Sarumathy S; Manigandan G · Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Randomized trial180 participantsVitamin B6
  24. Lower Plasma Vitamin B-6 is Associated with 2-Year Cognitive Decline in the Boston Puerto Rican Health Study.
    Palacios N; Scott T; Sahasrabudhe N; Gao X; Tucker KL · The Journal of nutrition · 2020
    Cohort study949 participantsVitamin B6
  25. Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review.
    Iolascon G; Gimigliano R; Bianco M; De Sire A; Moretti A; Giusti A; Malavolta N; Migliaccio S; Migliore A; Napoli N; Piscitelli P; Resmini G; Tarantino U; Gimigliano F · The journal of nutrition, health & aging · 2017
    Scoping review12 studies pooledVitamin B6
  26. Vitamin D and brain health: an observational and Mendelian randomization study.
    Navale SS; Mulugeta A; Zhou A; Llewellyn DJ; Hyppönen E · The American journal of clinical nutrition · 2022
    Cohort study427,690 participantsVitamin D
  27. The association between vitamin D and cognition: a systematic review.
    van der Schaft J; Koek HL; Dijkstra E; Verhaar HJ; van der Schouw YT; Emmelot-Vonk MH · Ageing research reviews · 2014
    Systematic review28 studies pooledVitamin D
  28. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults.
    Miller JW; Harvey DJ; Beckett LA; Green R; Farias ST; Reed BR; Olichney JM; Mungas DM; DeCarli C · JAMA neurology · 2016
    Cohort study382 participantsVitamin D
  29. Vitamin D insufficiency and cognitive impairment in Asians: a multi-ethnic population-based study and meta-analysis.
    Annweiler C; Milea D; Whitson HE; Cheng CY; Wong TY; Ikram MK; Lamoureux EL; Sabanayagam C · Journal of internal medicine · 2017
    Meta-analysis2,273 participants7 studies pooledVitamin D
  30. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
    Mowry EM; Waubant E; McCulloch CE; Okuda DT; Evangelista AA; Lincoln RR; Gourraud PA; Brenneman D; Owen MC; Qualley P; Bucci M; Hauser SL; Pelletier D · Annals of neurology · 2012
    Cohort study469 participantsVitamin D
  31. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    Sagaro GG; Traini E; Amenta F · Journal of Alzheimer's disease : JAD · 2023
    Meta-analysis8 studies pooledAlpha-GPC
  32. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M · Medicine · 2024
    Randomized trial119 participantsAlpha-GPC
  33. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsAlpha-GPC
  34. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
    Kerksick CM · Nutrients · 2024
    Randomized trial20 participantsAlpha-GPC
  35. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsAlpha-GPC
  36. Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.
    Leonard M; Dickerson B; Estes L; Gonzalez DE; Jenkins V; Johnson S; Xing D; Yoo C; Ko J; Purpura M; Jäger R; Faries M; Kephart W; Sowinski R; Rasmussen CJ; Kreider RB · Nutrients · 2024
    Randomized trial59 participantsAshwagandha
  37. Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.
    Rai HP; Mishra DN · Journal of psychopharmacology (Oxford, England) · 2025
    Randomized trial40 participantsAshwagandha
  38. Efficacy of Withania somnifera supplementation on adult's cognition and mood.
    Remenapp A; Coyle K; Orange T; Lynch T; Hooper D; Hooper S; Conway K; Hausenblas HA · Journal of Ayurveda and integrative medicine · 2022
    Randomized trial60 participantsAshwagandha
  39. A clinical assessment of the therapeutic effects of Ashwagandha root extract on cognitive performance, sleep, and fatigue in children aged 6-12 years.
    Saxena A; Lopresti A; Sharif M; Elon N; Suri R; Langade DK · Frontiers in nutrition · 2026
    Randomized trial85 participantsAshwagandha
  40. Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.
    Gopukumar K; Thanawala S; Somepalli V; Rao TSS; Thamatam VB; Chauhan S · Evidence-based complementary and alternative medicine : eCAM · 2022
    Randomized trial130 participantsAshwagandha
  41. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledBacopa
  42. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
    Kongkeaw C; Dilokthornsakul P; Thanarangsarit P; Limpeanchob N; Norman Scholfield C · Journal of ethnopharmacology · 2014
    Meta-analysis518 participants9 studies pooledBacopa
  43. Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
    Verma J; Rathi R; Anamika; Rathi B; Pandey VB · Journal of Ayurveda and integrative medicine · 2025
    Randomized trial180 participantsBacopa
  44. Plant-derived nootropics and human cognition: A systematic review.
    Lorca C; Mulet M; Arévalo-Caro C; Sanchez MÁ; Perez A; Perrino M; Bach-Faig A; Aguilar-Martínez A; Vilella E; Gallart-Palau X; Serra A · Critical reviews in food science and nutrition · 2023
    Systematic review256 studies pooledBacopa
  45. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
    Feng X; Fan S; Wei F · Frontiers in pharmacology · 2026
    Meta-analysis1,861 participants25 studies pooledBacopa
  46. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial.
    Rae C; Digney AL; McEwan SR; Bates TC · Proceedings. Biological sciences · 2003
    Randomized trial45 participantsCreatine
  47. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.
    Hersch SM; Gevorkian S; Marder K; Moskowitz C; Feigin A; Cox M; Como P; Zimmerman C; Lin M; Zhang L; Ulug AM; Beal MF; Matson W; Bogdanov M; Ebbel E; Zaleta A; Kaneko Y; Jenkins B; Hevelone N; Zhang H; Yu H; Schoenfeld D; Ferrante R; Rosas HD · Neurology · 2006
    Randomized trial64 participantsCreatine
  48. Creatine supplementation and cognitive performance in elderly individuals.
    McMorris T; Mielcarz G; Harris RC; Swain JP; Howard A · Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2008
    Randomized trial32 participantsCreatine
  49. Effects of high-load, velocity-intentional variable resistance training combined with creatine supplementation on neuroplasticity, oxidative stress, inflammation, physical function, cognitive performance and quality of life in older adults: A randomized, double-blind, placebo-controlled trial.
    Fernandez-Garrido J; Martin EG; Saez-Berlanga A; Gargallo-Bayo P; Gene-Morales J; Alix-Fages C; Jiménez-Martínez P; Caballero O; Salvador-Palmer R; Colado JC · Experimental gerontology · 2026
    Randomized trial103 participantsCreatine
  50. Single-Dose Creatine Reduces Sleep Deprivation-Induced Deterioration in Cognitive Performance.
    Gordji-Nejad A; Matusch A; Hengstler L; Beer S; Kroll T; Klein S; Elmenhorst D; Bauer A; Drzezga A · Nutrients · 2026
    Randomized trial29 participantsCreatine
  51. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledHuperzine
  52. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsHuperzine
  53. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsHuperzine
  54. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsHuperzine
  55. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsHuperzine
  56. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsAcetyl L-Carnitine
  57. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsAcetyl L-Carnitine
  58. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialAcetyl L-Carnitine
  59. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsAcetyl L-Carnitine
  60. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsAcetyl L-Carnitine
  61. A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia.
    Chengappa KN; Turkin SR; DeSanti S; Bowie CR; Brar JS; Schlicht PJ; Murphy SL; Hetrick ML; Bilder R; Fleet D · Schizophrenia research · 2013
    Randomized trialCarnosine
  62. Carnosine treatment for gulf war illness: a randomized controlled trial.
    Baraniuk JN; El-Amin S; Corey R; Rayhan R; Timbol C · Global journal of health science · 2013
    Randomized trial25 participantsCarnosine
  63. Carnosine supplementation improves cognitive outcomes in younger participants of the NEAT trial.
    O'Toole TE; Amraotkar AR; Gao H; Sears CG; Rai SN; Basner M; Bhatnagar A · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Randomized trial299 participantsCarnosine
  64. Anserine and carnosine supplementation in the elderly: Effects on cognitive functioning and physical capacity.
    Szcześniak D; Budzeń S; Kopeć W; Rymaszewska J · Archives of gerontology and geriatrics · 2014
    Observational studyCarnosine
  65. Histidine-containing dipeptide supplementation improves delayed recall: a systematic review and meta-analysis.
    Bell SM; Hariharan R; Laud PJ; Majid A; de Courten B · Nutrition reviews · 2024
    Meta-analysis10 studies pooledCarnosine
  66. [Curcumin in children with autism spectrum disorder: systemic inflammation, sensory regulation, and gut-brain interaction disorders. A randomized, double-blind, placebo-controlled clinical trial (CURATEA)].
    Vergara Serpa JJ; Sumalla Cano S · Nutricion hospitalaria · 2026
    Randomized trial60 participantsCurcumin
  67. Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: a systematic review and dose-response meta-analysis of randomized controlled trials.
    Sarraf P; Parohan M; Javanbakht MH; Ranji-Burachaloo S; Djalali M · Nutrition research (New York, N.Y.) · 2020
    Meta-analysis139 participants4 studies pooledCurcumin
  68. Curcumin-Rich Curry Consumption Is Associated with Lower Risk of Cognitive Decline and Incidence of Mild Cognitive Impairment or Dementia: An Asian Population-Based Study.
    Lu Y; Lee TS; Lim WS; Yap P; Cheong CY; Rawtaer I; Liew TM; Gwee X; Gao Q; Yap KB; Ng TP · Nutrients · 2025
    Cohort study2,920 participantsCurcumin
  69. Curcumin-Rich Curry Consumption and Neurocognitive Function from 4.5-Year Follow-Up of Community-Dwelling Older Adults (Singapore Longitudinal Ageing Study).
    Ng TP; Nyunt MSZ; Gao Q; Gwee X; Chua DQL; Yap KB · Nutrients · 2022
    Cohort study2,734 participantsCurcumin
  70. The effects of oral administration of curcumin-galactomannan complex on brain waves are consistent with brain penetration: a randomized, double-blinded, placebo-controlled pilot study.
    Khanna A; Das S S; Kannan R; Swick AG; Matthewman C; Maliakel B; Ittiyavirah SP; Krishnakumar IM · Nutritional neuroscience · 2022
    Randomized trial18 participantsCurcumin
  71. Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion's Mane Extracts on Cognitive Performance.
    La Monica MB; Raub B; Ziegenfuss EJ; Hartshorn S; Grdic J; Gustat A; Sandrock J; Ziegenfuss TN · Nutrients · 2023
    Randomized trialHericium mushroom
  72. Improvement of cognitive functions by oral intake of Hericium erinaceus.
    Saitsu Y; Nishide A; Kikushima K; Shimizu K; Ohnuki K · Biomedical research (Tokyo, Japan) · 2020
    Randomized trialHericium mushroom
  73. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.
    Mori K; Inatomi S; Ouchi K; Azumi Y; Tuchida T · Phytotherapy research : PTR · 2009
    Randomized trial30 participantsHericium mushroom
  74. A review of the effects of mushrooms on mood and neurocognitive health across the lifespan.
    Cha S; Bell L; Shukitt-Hale B; Williams CM · Neuroscience and biobehavioral reviews · 2024
    Systematic review34 studies pooledHericium mushroom
  75. Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study.
    Surendran G; Saye J; Binti Mohd Jalil S; Spreadborough J; Duong K; Shatwan IM; Lilley D; Heinrich M; Dodd GF; Surendran S · Frontiers in nutrition · 2025
    Randomized trial18 participantsHericium mushroom
  76. Dose-Response Effects of Short-Term Rhodiola rosea (Golden Root Extract) Supplementation on Anaerobic Exercise Performance and Cognitive Function in Resistance-Trained Athletes: A Randomized, Crossover, Double-Blind, and Placebo-Controlled Study.
    Koozehchian MS; Newton AT; Mabrey G; Bonness FM; Rafajlovska R; Naderi A · Nutrients · 2025
    Randomized trial27 participantsRhodiola
  77. A combination of green tea, rhodiola, magnesium and B vitamins modulates brain activity and protects against the effects of induced social stress in healthy volunteers.
    Boyle NB; Billington J; Lawton C; Quadt F; Dye L · Nutritional neuroscience · 2022
    Randomized trial100 participantsRhodiola
  78. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy.
    Panossian A; Wikman G; Sarris J · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2010
    Narrative reviewRhodiola
  79. Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.
    Darbinyan V; Kteyan A; Panossian A; Gabrielian E; Wikman G; Wagner H · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2001
    Randomized trial56 participantsRhodiola
  80. Effects of a Rhodiola rosea extract on mental resource allocation and attention: An event-related potential dual task study.
    Koop T; Dienel A; Heldmann M; Münte TF · Phytotherapy research : PTR · 2021
    Single-arm trial50 participantsRhodiola
  81. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial.
    Hidese S; Ogawa S; Ota M; Ishida I; Yasukawa Z; Ozeki M; Kunugi H · Nutrients · 2020
    Randomized trial30 participantsTheanine
  82. A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave® L-Theanine on Stress in a Healthy Adult Population.
    Evans M; McDonald AC; Xiong L; Crowley DC; Guthrie N · Neurology and therapy · 2021
    Randomized trialTheanine
  83. Effects of Tea (Camellia sinensis) or its Bioactive Compounds l-Theanine or l-Theanine plus Caffeine on Cognition, Sleep, and Mood in Healthy Participants: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Payne ER; Aceves-Martins M; Dubost J; Greyling A; de Roos B · Nutrition reviews · 2025
    Meta-analysis50 studies pooledTheanine
  84. Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task.
    Foxe JJ; Morie KP; Laud PJ; Rowson MJ; de Bruin EA; Kelly SP · Neuropharmacology · 2012
    Randomized trial27 participantsTheanine
  85. Effects of l-Theanine on Cognitive Function in Middle-Aged and Older Subjects: A Randomized Placebo-Controlled Study.
    Baba Y; Inagaki S; Nakagawa S; Kaneko T; Kobayashi M; Takihara T · Journal of medicinal food · 2021
    Randomized trialTheanine
  86. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledGinkgo
  87. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledGinkgo
  88. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledGinkgo
  89. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsGinkgo
  90. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsGinkgo
  91. [Cross-sectional association between the amino acid intake and episodic memory in middle- and old-aged community dwellers].
    Kinoshita K; Otsuka R; Takada M; Tsukamoto-Yasui M; Nishita Y; Tange C; Tomida M; Shimokata H; Imaizumi A; Arai H · Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics · 2021
    Cross-sectional study2,082 participantsHistidinePhenylalanine
  92. The effect of histidine on mental fatigue and cognitive performance in subjects with high fatigue and sleep disruption scores.
    Sasahara I; Fujimura N; Nozawa Y; Furuhata Y; Sato H · Physiology & behavior · 2016
    Randomized trial20 participantsHistidine
  93. Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.
    Terao I; Kodama W · Journal of Alzheimer's disease : JAD · 2024
    Meta-analysis4,599 participants10 studies pooledMelatonin
  94. Melatonin for sleep and cognitive outcomes in older adults with cognitive impairment: a meta-analysis of randomised controlled trials.
    Mdluli NT; Banda KJ; Chang YC · Age and ageing · 2025
    Meta-analysis516 participants10 studies pooledMelatonin
  95. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
    Wade AG; Farmer M; Harari G; Fund N; Laudon M; Nir T; Frydman-Marom A; Zisapel N · Clinical interventions in aging · 2015
    Randomized trial80 participantsMelatonin
  96. Early Oral Melatonin Supplementation Supports White Matter Maturation in Preterm Infants: Neuroprotective Insights of an Antioxidant Molecule.
    Garofoli F; Asteggiano C; Minniti ML; Accorsi P; Albertini R; Angelini M; Aversa S; Ballante E; Cabini RF; Caporali C; Cociglio S; Franco V; Longo S; Malerba L; Materia V; Mazzocchi L; Naboni C; Palmisani M; Pullega C; Pisoni C; Preda L; Riboli A; Risso FM; Rognone E; Savini G; Simoncelli AM; Villani P; Tzialla C; Pinelli L; Fazzi E; Chiapparini L; Borgatti R; Ghirardello S; Pichiecchio A; Orcesi S · Journal of pineal research · 2026
    Randomized trial54 participantsMelatonin
  97. Efficacy and Safety of Melatonin in Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Abouelmagd ME; Aldemerdash MA; Khatatbeh AA; Osman ASA; Abbas A; Allam S; AlEdani EM; Aldemerdash A; Monteith TS · Current pain and headache reports · 2026
    Meta-analysis788 participants9 studies pooledMelatonin
  98. The Association between Dietary Amino Acid Intake and Cognitive Decline 8 Years Later in Japanese Community-Dwelling Older Adults.
    Kinoshita K; Otsuka R; Takada M; Tsukamoto-Yasui M; Nishita Y; Tange C; Tomida M; Shimokata H; Kuzuya M; Imaizumi A; Arai H · The journal of nutrition, health & aging · 2021
    Cohort study427 participantsPhenylalanine
  99. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.
    Cleary MA; Walter JH; Wraith JE; White F; Tyler K; Jenkins JP · The Journal of pediatrics · 1995
    Non-randomized trial41 participantsPhenylalanine
  100. Improved dietary control results in improvements in indices of white matter structure in adults with phenylketonuria: the ReDAPT study.
    Kang MJY; Adamson C; Malpas CB; Winton-Brown T; Burgess N; Fazio T; Velakoulis D; Desmond P; Venkatraman V; De Jong G; Walterfang M · Acta neuropsychiatrica · 2026
    Single-arm trial7 participantsPhenylalanine
  101. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM · Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2006
    Single-arm trial19 participantsPhenylalanine
  102. Combined L-carnosine and L-tyrosine supplementation as an ergogenic strategy for physical and cognitive performance under fatigue in professional football players.
    Bilgin S; Bozyılan E; Buzdağlı Y; Karaç Öcal Y; Gürkan O; Toktaş S; İnan H; Egil İ; Yarayan YE · Frontiers in nutrition · 2026
    Randomized trial24 participantsTyrosine
  103. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands--A review.
    Jongkees BJ; Hommel B; Kühn S; Colzato LS · Journal of psychiatric research · 2016
    Narrative reviewTyrosine
  104. Influence of nutritional tyrosine on cognition and functional connectivity in healthy old humans.
    Hensel C; Becker M; Düzel S; Demuth I; Norman K; Steinhagen-Thiessen E; Gallinat J; Lindenberger U; Kühn S · NeuroImage · 2019
    Cross-sectional study286 participantsTyrosine
  105. Dietary Tyrosine Intake (FFQ) Is Associated with Locus Coeruleus, Attention and Grey Matter Maintenance: An MRI Structural Study on 398 Healthy Individuals of the Berlin Aging Study-II.
    Plini ERG; Melnychuk MC; Harkin A; Dahl MJ; McAuslan M; Kühn S; Boyle RT; Whelan R; Andrews R; Düzel S; Drewelies J; Wagner GG; Lindenberger U; Norman K; Robertson IH; Dockree PM · The journal of nutrition, health & aging · 2023
    Cross-sectional study398 participantsTyrosine
  106. Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating.
    Jongkees BJ · Cognitive, affective & behavioral neuroscience · 2021
    Randomized trial45 participantsTyrosine
  107. Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
    Zhang P; Cao Y; Chen S; Shao L · Pharmacology · 2021
    Randomized trial60 participantsVinpocetine
  108. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
    Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B · Journal of the neurological sciences · 2005
    Randomized trial13 participantsVinpocetine
  109. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
    Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A · Brain research bulletin · 2001
    Narrative reviewVinpocetine
  110. Effect of vinpocetine (cognitol™) on cognitive performances of a nigerian population.
    Ogunrin A · Annals of medical and health sciences research · 2014
    Non-randomized trial112 participantsVinpocetine
  111. [Study of the effects of vinpocetin on cognitive functions].
    Valikovics A; Csányi A; Németh L · Ideggyogyaszati szemle · 2012
    Clinical trialVinpocetine
  112. Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial).
    Janyajirawong R; Vilaichone RK; Sethasine S · Asian Pacific journal of cancer prevention : APJCP · 2021
    Randomized trial69 participantsZinc
  113. A preliminary report: effects of zinc and micronutrient repletion on growth and neuropsychological function of urban Chinese children.
    Penland JG; Sandstead HH; Alcock NW; Dayal HH; Chen XC; Li JS; Zhao F; Yang JJ · Journal of the American College of Nutrition · 1997
    Randomized trial372 participantsZinc
  114. Association between zinc deficiency and cognitive decline in community-dwelling older adults.
    Marchetti MF; Silva GMD; Freiria CN; Borim FSA; Brito TRP; Milanski M; Corona LP · Ciencia & saude coletiva · 2022
    Cross-sectional study591 participantsZinc
  115. Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study.
    Marcellini F; Giuli C; Papa R; Gagliardi C; Dedoussis G; Herbein G; Fulop T; Monti D; Rink L; Jajte J; Mocchegiani E · Biogerontology · 2007
    Cross-sectional study853 participantsZinc
  116. Zinc alleviates stroke development through autophagy-mediated modulation of immune microenvironment.
    Qiu Z; Liu X; Li J; Yin H; Luo J; Lin Z; Rexiati M; Abulaiti A; Yasen A; Xing L; Aili D; Meng B; Li X; You Z; He J; Huang C; Qian Z; Chen J · Frontiers in immunology · 2025
    OtherZinc